On February 27, 2020 MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer, reported that the Company’s management will attend the following investor conferences in March (Press release, MacroGenics, FEB 27, 2020, View Source [SID1234554867]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Cowen and Company 40th Annual Health Care Conference. MacroGenics’ management will present an overview of the company in Boston, MA on Tuesday, March 3, 2020, at 10:40 a.m. ET.
Barclays Global Healthcare Conference. MacroGenics’ management will present an overview of the company in Miami Beach, FL on Wednesday, March 11, 2020, at 10:45 a.m. ET.
Webcasts of the presentations may be accessed under "Events & Presentations" in the Investor Relations section of MacroGenics’ website at View Source The Company will maintain archived replays of these webcasts on its website for 30 days after the conference.